Table 1.
Balkan countries | New cases* | Deaths* | 5-year prevalence** | ASR incidence# | ASR mortality# |
---|---|---|---|---|---|
Albania | 374 (4.51) | 186 (3.96) | 928 (31.63) | 8.4 | 3.7 |
Bosnia and Herzegovina | 1,804 (12.54) | 1,074 (11.92) | 4,441 (126.75) | 26.1 | 13.3 |
Bulgaria | 4,553 (12.87) | 2,687 (14.04) | 11,751 (166.99) | 28.5 | 14.9 |
Croatia | 3,356 (13.31) | 2,174 (15.06) | 8,955 (215.01) | 34.1 | 18.9 |
Greece | 7,117 (10.56) | 3,384 (10.16) | 19,570 (175.64) | 26.2 | 9.7 |
Montenegro | 208 (8.79) | 114 (8.86) | 548 (87.09) | 18.6 | 9.2 |
Romania | 10,856 (13.01) | 6,155 (12.09) | 28,364 (144.86) | 26.7 | 13.7 |
Serbia | 6,049 (12.61) | 3,187 (11.84) | 15,347 (175.15) | 36.7 | 16.8 |
Slovenia | 1,970 (14.59) | 737 (11.52) | 5,637 (270.84) | 41.1 | 12.5 |
The Republic of North Macedonia | 984 (12.60) | 472 (11.47) | 2,429 (116.50) | 28.4 | 12.5 |
Turkey | 19,689 (9.35) | 9,996 (8.56) | 48,725 (59.48) | 21.0 | 10.2 |
Absolute number (% of total number of all new/death cancer site cases);
Prevalence was shown as absolute number (as proportion of the population per 100,000 persons);
Age-standardized (World) incidence and mortality rates.